Main
>
NEUROLOGY.
>
Endothelin Receptor AntAgonists
>
ClazoSentan.
>
NonGeneric ClazoSentan
NonGeneric ClazoSentan's subsections
Clinical Status: Phase II (10.03)
Company:
NonGeneric ClazoSentan's products
This section has no products